Company positions Saudi Arabia as strategic MENA hub and anticipates second-half 2026 revenue increase with expectations of 10% revenue growth year-over-year for FY2026 from $6.6M in FY2025 NANCHANG, China, April 02, 2026 (GLOBE NEWSWIRE) — Ruanyun Edai Technology Inc. (NASDAQ: RYET) (“Ruanyun Edai Technology,” “RYET,” or the “Company”), an AI-driven education technology company focused on intelligent content recognition, automated assessment and next-generation learning systems,, today announced the establishment of its Regional Headquarters (“RHQ”) in the Kingdom of Saudi Arabia, marking a significant milestone in the Company’s global expansion strategy, long-term commitment to the Middle East and North Africa (MENA) region and a significant step in transition toward the previously announced Formind Group, which remains subject...

LAKE FOREST, Calif., April 02, 2026 (GLOBE NEWSWIRE) — Del Taco, the nation’s second-largest Mexican quick service restaurant* is launching a variety of limited-time, 90s-inspired classics. The throwback lineup features the return of fan-favorite Big Fat Tacos, alongside the popular Dragon Fruit Blueberry Poppers and Mini Sweet Cream Churros. Available beginning April 2 at participating locations, the craveable menu items deliver a mix of bold flavors that authentically capture the essence of an iconic era. Adding to the nostalgia, Del Taco is introducing Del Flipz, a retro-inspired collectible modeled after a popular 90s tabletop craze featuring printed milk bottle caps. For a limited time, guests can indulge in Big Fat Tacos, one of Del Taco’s most requested “bring it back” items. Served on a buttery toasted flatbread and layered...

2025 financial highlights:Cash and cash equivalents totaled €101.1 million as of December 31, 2025 Revenues amounting to €65.4 million for the period ended December 31, 2025, including €43.6 million in milestones and €21.8 in royalties from Ipsen Cash runway beyond the end of 20282026 business and pipeline outlook:PBC: Royalty stream expected to increase, building on Ipsen’s strong 2025 performance MASH diagnostics: Sales acceleration expected with LDT, initiation of IVD development CCA: Additional Phase 1 cohort data expected mid‑year, Phase 2 initiation targeted in 2H26 ACLF: Phase 2 initiation with lead asset NTZ anticipated in 2H26, data expected in 2027 PSC: Ipsen‑led Phase 3 study initiated in February 2026Lille, France; Cambridge, MA; Zurich, Switzerland; April 2, 2026 – GENFIT (Euronext: GNFT), a late-stage biopharmaceutical...

“Seen in the Wild” sweepstakes celebrates outdoor adventure across Twins Territory featuring T.C. Bear’s custom RV MINNEAPOLIS and ST. PAUL, Minn., April 02, 2026 (GLOBE NEWSWIRE) — Winnebago Industries (NYSE: WGO), a leading manufacturer of premium outdoor recreation products, and the Minnesota Twins today celebrate year three as the team’s Official Outdoor Adventure Partner, unveiling a new fan-focused activation, Seen in the Wild, that brings the spirit of Twins baseball beyond the ballpark and into the great outdoors across Twins Territory ahead of the Twins home opener. Building on last season’s Hit It to Win It contest, which aimed to celebrate moments of success inside Target Field, Seen in the Wild shifts the focus outside the stadium to an RV and the open road, highlighting the many ways Twins fans experience adventure,...

Primary Mortgage Market Survey®U.S. weekly average mortgage rates as of 04/02/2026MCLEAN, Va., April 02, 2026 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today released the results of its Primary Mortgage Market Survey® (PMMS®), showing the 30-year fixed-rate mortgage (FRM) averaged 6.46%. “The 30-year fixed-rate mortgage edged up, averaging 6.46% this week,” said Sam Khater, Freddie Mac’s Chief Economist. “With spring homebuying season in full swing, aspiring buyers should remember to shop around for the best mortgage rate, as they can potentially save thousands of dollars by getting multiple quotes.” News FactsThe 30-year FRM averaged 6.46% as of April 2, 2026, up from last week when it averaged 6.38%. A year ago at this time, the 30-year FRM averaged 6.64%. The 15-year FRM averaged 5.77%, up from last week when it...

Approval is based on 96-week data from 2 pivotal trials showing majority of EYLEA HD patients maintained their visual and anatomic improvements with extended dosing intervals New EYLEA HD dosing regimen allows patients with wAMD and DME to be treated as infrequently as 2 to 3 times a year, further extending the widest range of dosing intervals of any approved injectable anti-VEGF TARRYTOWN, N.Y., April 02, 2026 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the extension of dosing intervals for EYLEA HD® (aflibercept) up to every 20 weeks for patients with wet age-related macular degeneration (wAMD) and diabetic macular edema (DME) following one year of successful response based on visual and anatomic outcomes. As part of the approval,...

EssilorLuxottica acquires a stake in Top Charoen,reinforcing its presence in Thailand Paris, France and Bangkok, Thailand (2 April 2026) – EssilorLuxottica and Top Charoen today announced that they have closed a transaction for EssilorLuxottica to become the partner of Top Charoen through the acquisition of a meaningful stake, cementing the long-standing relationship between the two companies. Top Charoen is Thailand’s largest retail chain with over 2,000 stores across all regions of the country. Thailand is a strategic hub for EssilorLuxottica’s global manufacturing and business operations. The partnership with Top Charoen further strengthens EssilorLuxottica’s commitment to elevating vision care across the region and worldwide, while bringing us closer to consumers to anticipate their future needs. Top Charoen was founded in 1947 with...

Paris, April 2nd, 2026 Information on total number of voting rights and shares in the share capital as of March 31, 2026 (Article L.233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the AMF)Date Total number of shares in the capital Total number of voting rights31/03/2026 144,161,839 144,161,839Attachment2. URW SE – 2026 03 31 – Information on total number of voting rights and shares in the share capital

Ilkka Oyj                               Stock Exchange Release 2 April 2026, at 07:00 p.m. EEST Ilkka Oyj: Acquisition of own shares on 2 April 2026Date 2 April 2026  Exchange transaction Buy  Share trading code ILKKA2  Amount, shares 1,732  Average price/share (EUR) 4.2210  Total cost (EUR) 7,310.77  After the acquisitions Ilkka Oyj holds a total of  147,400 treasury shares (ILKKA2). On behalf of Ilkka Oyj Danske Bank A/S, Finland Branch Antti Väliaho                         Jonathan Nyberg For more information, please contact:Olli Pirhonen, CEO, Ilkka Oyjolli.pirhonen@ilkka.com DISTRIBUTIONNasdaq HelsinkiMain mediawww.ilkka.com Ilkka Oyj in briefIlkka is a marketing and technology company that offers professional, data and technology services in digital marketing and communications. The core of Ilkka’s business...

Strasbourg, France & Schiphol, Netherlands, April 2, 2026, 5:45 p.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and NEC Bio B.V. (“NEC”), a wholly owned subsidiary of NEC Corporation (TSE: 6701), a leader in IT, network and AI technologies, announce the signing of a license agreement to advance the clinical development of TG4050, an individualized neoantigen therapeutic vaccine (INTV) in the adjuvant treatment of resected HPV-negative head and neck cancer. TG4050 is an individualized immunotherapy based on an MVA viral vector incorporating neoantigens selected using NEC’s AI-enabled prediction platform. It is currently being evaluated in patients with head and neck cancer with the aim of preventing relapse and extending disease-free survival...